Baudax Bio, Inc.
BXRXQ
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 64.42% | -337.56% | -120.75% | -197.42% | 69.64% |
| Total Depreciation and Amortization | 110.84% | -55.83% | -60.12% | -67.50% | -71.18% |
| Total Amortization of Deferred Charges | -89.91% | -94.95% | -96.64% | -97.48% | -75.00% |
| Total Other Non-Cash Items | 40.43% | 144.75% | 128.74% | 201.19% | -209.47% |
| Change in Net Operating Assets | 183.18% | 280.58% | -57.04% | 141.43% | 126.80% |
| Cash from Operations | 60.97% | 65.19% | 36.74% | 43.59% | 28.48% |
| Capital Expenditure | 83.46% | 100.00% | 100.00% | 100.00% | 68.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.27% | -322.22% | 199.89% |
| Cash from Investing | -98.79% | -98.82% | -100.27% | 79.38% | 194.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -366.01% | -1,866.19% | -- | -- | -- |
| Issuance of Common Stock | -26.61% | 23.49% | -32.16% | -51.58% | -67.65% |
| Repurchase of Common Stock | 100.00% | 99.03% | 99.07% | 97.96% | 94.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 58.67% | 39.80% | 2.82% | 82.15% | 86.56% |
| Cash from Financing | -49.22% | -9.75% | -48.85% | -50.93% | -66.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 190.51% | -- | -- |
| Net Change in Cash | 42.09% | 81.22% | 59.69% | 26.43% | 7.23% |